PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2014.1772015474853-861ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative ResectionHye Won Hwang, Sang Yun Ha, Heejin Bang, Cheol-Keun Parkhttp://e-crt.org/upload/pdf/crt-2014-177.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2014.177, http://www.e-crt.org/upload/pdf/crt-2014-177.pdf
Journal of Hepatocellular Carcinoma10.2147/jhc.s3932862023Volume 10193-202Inflammation-Related Marker NrLR Predicts Prognosis in AFP-Negative HCC Patients After Curative ResectionQionglan Wu, Jinhua Zeng, Jianxing Zenghttps://www.dovepress.com/getfile.php?fileID=87363, https://www.dovepress.com/getfile.php?fileID=87363
Pathobiology10.1159/0003464762013803155-162Glyoxylate Reductase/Hydroxypyruvate Reductase: A Novel Prognostic Marker for Hepatocellular Carcinoma Patients after Curative ResectionYinglian Pan, Runzhou Ni, Qingchun Deng, Xiaodong Huang, Yixin Zhang, Cuihua Lu, Feifei Li, Da Huang, Song He, Buyou Chenhttps://www.karger.com/Article/Pdf/346476, https://www.karger.com/Article/Pdf/346476
HPB10.1016/j.hpb.2019.10.1997201921S367Prognostic analysis of hepatocellular carcinoma greater than 5 cm in diameter after curative resectionJae Do Yang, Sung Woo Ahn, Hee Chul Yuhttps://api.elsevier.com/content/article/PII:S1365182X1932739X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1365182X1932739X?httpAccept=text/plain
Disease Markers10.1155/2017/3765279201720171-1Corrigendum to “Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma”Xiao-Meng Dai, Tao Huang, Sheng-Li Yang, Xiu-Mei Zheng, George G. Chen, Tao Zhanghttp://downloads.hindawi.com/journals/dm/2017/3765279.pdf, http://downloads.hindawi.com/journals/dm/2017/3765279.xml, http://downloads.hindawi.com/journals/dm/2017/3765279.pdf
International Journal of Surgery10.1016/j.ijsu.2017.06.069201737385Peer review report 1 on “Prognostic nomogram for patients with non-B non-C hepatocellular carcinoma after curative liver resection”https://api.elsevier.com/content/article/PII:S1743919117305320?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1743919117305320?httpAccept=text/plain
International Journal of Surgery10.1016/j.ijsu.2017.07.020201737404Peer review report 2 on “Prognostic nomogram for patients with non-B non-C hepatocellular carcinoma after curative liver resection”https://api.elsevier.com/content/article/PII:S1743919117305678?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1743919117305678?httpAccept=text/plain
International Journal of Surgery10.1016/j.ijsu.2017.07.021201737395Peer review report 3 on “Prognostic nomogram for patients with non-B non-C hepatocellular carcinoma after curative liver resection”https://api.elsevier.com/content/article/PII:S174391911730568X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S174391911730568X?httpAccept=text/plain
Translational Oncology10.1016/j.tranon.2014.02.011201472248-255Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative ResectionWeijia Liao, Jingmei Zhang, Qun Zhu, Liling Qin, Wenmin Yao, Biao Lei, Wuxiang Shi, Shengguang Yuan, Syed Abdul Tahir, Junfei Jin, Songqing Hehttps://api.elsevier.com/content/article/PII:S1936523314000126?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1936523314000126?httpAccept=text/plain
HPB10.1016/j.hpb.2020.11.401202123S163Effectiveness of the Albumin-bilirubin Score as a Prognostic Factor for Early Recurrence after Curative Hepatic Resection for Hepatocellular CarcinomaY.H. Lee, Y.S. Koh, C.K. Cho, H.J. Kimhttps://api.elsevier.com/content/article/PII:S1365182X20316452?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1365182X20316452?httpAccept=text/plain